Anderman Todd, Chief Legal Officer at Ocular Therapeutix ($OCUL), made one open market sale of company shares in the past year, totaling $137,369 with the most recent on October 8, 2025. His sales volume ranks 9,121st among 11,678 insiders, well below the average of $8.6 million per person across about 6.4 transactions. He recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Anderman Todd | Chief Legal Officer | A | Common Stock | 64900 | $0.00 | 152,468.0000 | 187,241,483 | 74.11% | 0.03% |
| Jan. 2, 2026 | OCULAR THERAPEUTIX, INC | $OCUL | Anderman Todd | Chief Legal Officer | A | Stock Option (Right to Buy) | 197650 | $0.00 | 197,650.0000 | 187,241,483 | 9999.99% | 0.11% |
| Oct. 8, 2025 | OCULAR THERAPEUTIX, INC | $OCUL | Anderman Todd | Chief Legal Officer | S | Common Stock | 11132 | $12.34 | 87,568.0000 | 183,919,808 | 11.28% | 0.01% |
| Oct. 7, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Anderman Todd | Chief Legal Officer | A | Common Stock | 98700 | $0.00 | 98,700.0000 | 166,992,735 | 9999.99% | 0.06% |
| Oct. 7, 2024 | OCULAR THERAPEUTIX, INC | $OCUL | Anderman Todd | Chief Legal Officer | A | Stock Option (Right to Buy) | 296500 | $0.00 | 296,500.0000 | 166,992,735 | 9999.99% | 0.18% |